Market Cap Chart

Historical Market Cap Data

View and export this data back to 2006. Start Trial.
Date Value
October 23, 2026 1.696B
October 22, 2026 1.734B
October 21, 2026 1.658B
October 20, 2026 1.658B
October 19, 2026 1.589B
October 16, 2026 1.597B
October 15, 2026 1.669B
October 14, 2026 1.594B
October 13, 2026 1.652B
October 12, 2026 1.718B
October 09, 2026 1.629B
October 08, 2026 1.580B
October 07, 2026 1.565B
October 06, 2026 1.609B
October 05, 2026 1.637B
October 02, 2026 1.531B
October 01, 2026 1.512B
September 30, 2026 1.576B
September 29, 2026 1.583B
September 28, 2026 1.534B
September 25, 2026 1.545B
September 24, 2026 1.515B
September 23, 2026 1.531B
September 22, 2026 1.577B
September 21, 2026 1.553B
Date Value
September 18, 2026 1.554B
September 17, 2026 1.570B
September 16, 2026 1.603B
September 15, 2026 1.628B
September 14, 2026 1.658B
September 11, 2026 1.615B
September 10, 2026 1.350B
September 09, 2026 1.372B
September 08, 2026 1.403B
September 04, 2026 1.443B
September 03, 2026 1.425B
September 02, 2026 1.403B
September 01, 2026 1.406B
August 31, 2026 1.431B
August 28, 2026 1.441B
August 27, 2026 1.461B
August 26, 2026 1.438B
August 25, 2026 1.425B
August 24, 2026 1.411B
August 21, 2026 1.447B
August 20, 2026 1.418B
August 19, 2026 1.489B
August 18, 2026 1.455B
August 17, 2026 1.443B
August 14, 2026 1.495B

Market Capitalization Definition

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.

Read full definition.

Market Cap Range, Past 5 Years

View Market Cap Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Benchmarks

View Market Cap Benchmarks
Start Trial
Artivion, Inc. 1.135B
Glaukos Corp. 10.53B
TransMedics Group, Inc. 2.450B
Abbott Laboratories 179.44B
AngioDynamics, Inc. 524.58M

Market Cap Related Metrics

PS Ratio 2.093
Price 11.11
Earnings Yield -6.45%